Regulatory Compliance

DUBAI – October 06, 2026 -- Caladan's Dubai entity, CLDN Broker Dealer FZE, has secured In-Principle Approval (IPA) from Dubai's Virtual Assets Regulatory Authority (VARA) for Broker-Dealer Services, under reference IPA/26/09/004, dated October 06, 2026.

VARA grants preliminary clearance, not a full license

The approval allows Caladan to proceed toward a full VARA license but does not yet authorize the firm to provide broker-dealer services in or from Dubai. Once licensed, CLDN Broker Dealer FZE will serve institutional clients exclusively, with no retail client access permitted.

New York – – October 06, 2026 -- Solana Foundation launched Solana DvP, an open-source delivery-versus-payment escrow program that compresses securities settlement from one to two days into a single atomic transaction settled in seconds.

Solana DvP replaces bespoke smart contracts with one standard settlement rail

Released under the MIT license, the API provides atomic settlement, isolated escrow, and enforced deadlines for institutional trades on Solana's public blockchain. Until now, institutional onchain trades relied on custom-built smart contracts rather than a shared standard.

Lake Oswego – October 06, 2026 -- The Greenbrier Companies (NYSE: GBX) has rejected antidumping and countervailing duty petitions filed by UTLX Manufacturing LLC, a Berkshire Hathaway subsidiary, over railway tank cars and parts, vowing to defend its record before the U.S. Department of Commerce and the U.S. International Trade Commission.

Greenbrier disputes claims it abandoned U.S. tank car production

Greenbrier operates a purpose-built tank car manufacturing facility in Marmaduke, Arkansas, where American employees currently build tank cars. The company noted that UTLX's own petition identifies Greenbrier as a U.S. producer and acknowledges its domestic tank car output in 2025.

New York – October 06, 2026 -- Rain, a stablecoin payments infrastructure provider, has filed an application with the Office of the Comptroller of the Currency (OCC) to establish Rain National Trust Bank (RNTB), a proposed federally supervised trust bank headquartered in New York.

RNTB would consolidate custody, reserve management and stablecoin issuance under OCC oversight

If approved, the uninsured national trust bank will provide fiduciary custody of digital assets and US dollars, reserve management for permitted stablecoin issuers, and issuance and redemption of US dollar-backed stablecoins for institutional clients. The entity will not accept deposits, offer consumer accounts, or make commercial loans. Client assets would be segregated from the bank's own holdings and not treated as liabilities, with stablecoin reserves barred from being pledged, lent or reused.

Edmonton – October 06, 2026 -- Aurora Cannabis Inc. (TSX: ACB; NASDAQ: ACB) confirmed that Curaleaf Holdings, Inc. has yet to file a formal Notice of Variation and Change despite announcing intent to revise its hostile takeover bid to an implied US$5.00 per share, comprising 0.4013 Curaleaf subordinate voting shares plus US$1.00 cash per Aurora share.

SEATTLE – October 06, 2026 -- Mozart Therapeutics presented three new data sets on its lead candidate MTX-101 at the 62nd Annual Meeting of the European Association for the Study of Diabetes (EASD), held September 28–October 06, 2026, in Milan, Italy, advancing the bispecific antibody toward a planned Phase 2a trial in Stage 3 type 1 diabetes with enrollment targeted for the first half of 2027.

Phase 1a/b data show MTX-101 is well tolerated and may affect C-peptide levels

The first presentation detailed safety, pharmacokinetic and pharmacodynamic results from a Phase 1a/b study in healthy adults and type 1 diabetes patients. Clinical data collected to date indicate MTX-101 has been relatively safe and well tolerated, with early signals suggesting a positive effect on C-peptide levels in patients with Stage 3 disease.

Palm Beach Gardens, Fla. – October 06, 2026 -- AMPERA has submitted a comprehensive Regulatory Engagement Plan to the U.S. Nuclear Regulatory Commission, with plans to file its combined manufacturing and fuel fabrication facility license application by October 2027.

AMPERA targets October 2027 for combined reactor and fuel facility license filing

The submission marks the pre-application phase of the NRC licensing process for AMPERA's advanced reactor technology. The company is providing regulators with detailed design features, methodologies and analysis intended to accelerate and de-risk the review period ahead of the 2027 filing.

North Chicago / Copenhagen – October 06, 2026 -- AbbVie and Genmab A/S reported that epcoritamab combined with standard R-CHOP chemotherapy reduced the risk of disease progression or death by 51% versus R-CHOP alone in newly diagnosed diffuse large B-cell lymphoma (DLBCL) patients, based on topline Phase 3 data.

Trial hits statistical significance with hazard ratio of 0.49

The Phase 3 EPCORE DLBCL-2 study showed a hazard ratio of 0.49 (95% CI 0.36-0.67; p-value less than 0.0001) for progression-free survival in patients with an International Prognostic Index (IPI) score of 2 to 5. For the trial's primary endpoint population, patients with IPI scores of 3 to 5, the hazard ratio was also 0.49 (95% CI 0.35-0.69; p-value less than 0.0001).

Sheridan, Wyo. – October 05, 2026 -- The global in vitro diagnostics (IVD) quality control market is set to climb from $1.7 billion in 2026 to $2.2 billion by 2031, a 5.3% compound annual growth rate, according to a new study by Wissen Research.

Rising testing volumes and regulatory pressure push labs toward automated QC

Growth is driven by expanding testing complexity across clinical chemistry, immunoassay, hematology, and molecular diagnostics, combined with tightening regulatory requirements such as CLIA in the United States. Laboratories are increasingly adopting internal quality controls, third-party control materials, and external quality assessment programs as standard practice.

Novi, Michigan – October 05, 2026 -- WZC Networking, an RF engineering firm that designs and tests in-building radio systems for first responders, is marking its 20th anniversary after resolving two emergency communication failures at Michigan healthcare and senior living facilities. Founded in 2006 by RF engineer John Wierzgac, the company has become a benchmark provider of Emergency Responder Communication Enhancement Systems (ERCES) and Public Safety Distributed Antenna Systems under NFPA 1225 and IFC Section 510 code requirements.